Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jonas

Showing results (771-780 of 828) with videos related to

Pageof 83
Sort By:
Toxics|May 12, 2019
Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and ScienceMichael A Malfatti, Bruce A Buchholz, Heather A Enright, et al.
The Annals of Thoracic Surgery|September 29, 2014
The importance of patient-specific preoperative factors: an analysis of the society of thoracic surgeons congenital heart surgery databaseJeffrey Phillip Jacobs, Sean M O'Brien, Sara K Pasquali, et al.
Blood|August 12, 2024
Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidineHartmut Döhner, Keith W Pratz, Courtney D DiNardo, et al.
The Lancet. Oncology|January 18, 2018
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b studyCourtney D DiNardo, Keith W Pratz, Anthony Letai, et al.
Journal of Hematology & Oncology|January 17, 2025
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trialJorge E Cortes, Gail J Roboz, Maria R Baer, et al.
Brain Research|February 28, 2012
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiencyKambiz N Alavian, Steven I Dworetzky, Laura Bonanni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2008
Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neuronsHongmei Li, Yingbei Chen, Adrienne F Jones, et al.
The Annals of Thoracic Surgery|March 12, 2019
Refining The Society of Thoracic Surgeons Congenital Heart Surgery Database Mortality Risk Model With Enhanced Risk Adjustment for Chromosomal Abnormalities, Syndromes, and Noncardiac Congenital Anatomic AbnormalitiesJeffrey P Jacobs, Sean M O'Brien, Kevin D Hill, et al.
Leukemia Research|June 23, 2022
Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer centerTamer Othman, Benjamin N Moskoff, Gwendolyn Ho, et al.
Nature Cell Biology|September 20, 2011
Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthaseKambiz N Alavian, Hongmei Li, Leon Collis, et al.
Pageof 83

Showing results (771-780 of 828) with videos related to

Sort By:
Pageof 83
Toxics|May 12, 2019
Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and ScienceMichael A Malfatti, Bruce A Buchholz, Heather A Enright, et al.
The Annals of Thoracic Surgery|September 29, 2014
The importance of patient-specific preoperative factors: an analysis of the society of thoracic surgeons congenital heart surgery databaseJeffrey Phillip Jacobs, Sean M O'Brien, Sara K Pasquali, et al.
Blood|August 12, 2024
Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidineHartmut Döhner, Keith W Pratz, Courtney D DiNardo, et al.
The Lancet. Oncology|January 18, 2018
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b studyCourtney D DiNardo, Keith W Pratz, Anthony Letai, et al.
Journal of Hematology & Oncology|January 17, 2025
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trialJorge E Cortes, Gail J Roboz, Maria R Baer, et al.
Brain Research|February 28, 2012
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiencyKambiz N Alavian, Steven I Dworetzky, Laura Bonanni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2008
Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neuronsHongmei Li, Yingbei Chen, Adrienne F Jones, et al.
The Annals of Thoracic Surgery|March 12, 2019
Refining The Society of Thoracic Surgeons Congenital Heart Surgery Database Mortality Risk Model With Enhanced Risk Adjustment for Chromosomal Abnormalities, Syndromes, and Noncardiac Congenital Anatomic AbnormalitiesJeffrey P Jacobs, Sean M O'Brien, Kevin D Hill, et al.
Leukemia Research|June 23, 2022
Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer centerTamer Othman, Benjamin N Moskoff, Gwendolyn Ho, et al.
Nature Cell Biology|September 20, 2011
Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthaseKambiz N Alavian, Hongmei Li, Leon Collis, et al.
Pageof 83